LIDODERM (lidocaine) by Teikoku Seiyaku is clinical pharmacology pharmacodynamics lidocaine is an amide-type local anesthetic agent and is suggested to stabilize neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction of impulses. First approved in 1999.
Drug data last refreshed 2h ago · AI intelligence enriched 1w ago
LIDODERM is a topical lidocaine patch (5%) approved in 1999 for localized pain relief via transdermal delivery. It works by stabilizing neuronal membranes and inhibiting ionic fluxes required for pain signal conduction, producing analgesia without complete sensory block. The patch delivers minimal systemic absorption (~3% of applied dose), making it a low-risk topical option for post-herpetic neuralgia and localized pain conditions.
Product is in late-stage lifecycle with modest Part D spending ($3M, 2215 claims in 2023), indicating shrinking team and focus on defending market share against generics.
CLINICAL PHARMACOLOGY Pharmacodynamics Lidocaine is an amide-type local anesthetic agent and is suggested to stabilize neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction of impulses. The penetration of lidocaine into intact skin after application of…
Worked on LIDODERM at Teikoku Seiyaku? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Amide Local Anesthetic
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region
Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg Telangiectasias
Lidocaine for LESS Postoperative Shoulder Pain Alleviation
A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine
A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult Participants
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on LIDODERM offers limited career acceleration given its mature, genericizing status; roles focus on defensive commercial strategies and market maintenance rather than innovation. This is best suited for professionals seeking stable, operational positions rather than high-growth brand leadership opportunities.